Literature DB >> 4440581

The "on-off" response to chronic L-DOPA treatment of Parkinsonism.

R D Sweet, F H McDowell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4440581

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  10 in total

1.  The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.

Authors:  W Birkmayer; P Riederer; M B Youdim; W Linauer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

2.  Treatment of the on-off syndrome in Parkinsonism with low dose bromocriptine in combination with levodopa.

Authors:  D N Bateman; A Coxon; N J Legg; J L Reid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-12       Impact factor: 10.154

Review 3.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

4.  Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon.

Authors:  J Balldin; S Edén; A K Granérus; K Modigh; A Svanborg; J Wålinder; L Wallin
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

5.  "On-off" phenomenon in Parkinson's disease: correlation to the concentration of dopa in plasma.

Authors:  T Eriksson; T Magnusson; A Carlsson; A Linde; A K Granérus
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

6.  [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.

Authors:  Y Clement-Cormier; C E Smith
Journal:  Neurochem Res       Date:  1980-06       Impact factor: 3.996

7.  Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonism.

Authors:  N R Cutler; S A Reines; L F McLean; J J Sramek; A G Porras; E L Hand
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

8.  Deprenyl in Parkinson disease: personal experience.

Authors:  P Giovannini; M P Grassi; G Scigliano; I Piccolo; P Soliveri; T Caraceni
Journal:  Ital J Neurol Sci       Date:  1985-06

9.  Predictors for improvement after electroconvulsive therapy in parkinsonian patients with on-off symptoms.

Authors:  J Balldin; A K Granérus; G Lindstedt; K Modigh; J Wålinder
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

10.  Deprenyl in the management of response fluctuations in patients with Parkinson's disease on levodopa.

Authors:  M Schachter; C D Marsden; J D Parkes; P Jenner; B Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.